Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical issues in interpreting clinical trials.

D L DeMets1

  • 1Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, 600 Highland Avenue, K6-446, Madison, WI 53792-4675, USA. demets@biostat.wisc.edu

Journal of Internal Medicine
|April 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

Controlled clinical trials·2001
Same author

Statistical issues relating to international differences in clinical trials.

American heart journal·2001
Same author

Effect of carvedilol on survival in severe chronic heart failure.

The New England journal of medicine·2001
Same author

The Data and Safety Monitoring Committee: Some final thoughts.

American heart journal·2001
Same author

An overview of group sequential methods in longitudinal clinical trials.

Statistical methods in medical research·2001
Same author

The role of surrogate outcome measures in evaluating medical devices.

Surgery·2000
Same journal

Multicenter validation of a severity index model for predicting postoperative acute kidney injury.

Journal of internal medicine·2026
Same journal

The changing epidemiology of human type 2 diabetes-associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities.

Journal of internal medicine·2026
Same journal

Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans.

Journal of internal medicine·2026
Same journal

Authors' reply: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026
Same journal

Regarding: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026
Same journal

Brain pathology in relation to somatic diseases: Exploring the body-brain crosstalk.

Journal of internal medicine·2026
See all related articles

This study highlights potential biases in randomized clinical trial data analysis. Adhering to principles like intent-to-treat is crucial for reliable therapeutic evaluations.

Area of Science:

  • Clinical Research Methodology
  • Biostatistics
  • Evidence-Based Medicine

Background:

  • Randomized clinical trials (RCTs) are vital for assessing new medical interventions.
  • Ensuring reliable and unbiased trial results requires meticulous design and execution.
  • Data analysis presents unique challenges that can introduce bias if not handled carefully.

Purpose of the Study:

  • To identify and describe common issues in the analysis of randomized clinical trial data that can lead to bias.
  • To emphasize the importance of adhering to specific analytical principles for accurate interpretation of trial outcomes.

Main Methods:

  • The study reviews established principles and potential pitfalls in the statistical analysis of clinical trial data.
  • It discusses several key areas where analytical bias can be introduced.

Related Experiment Videos

Main Results:

  • Challenges in interpreting trial analyses arise from issues such as the intent-to-treat principle.
  • The use of surrogate outcome measures, subgroup analyses, handling of missing data, and noninferiority trial designs can also introduce bias.

Conclusions:

  • Careful consideration of analytical principles is essential to prevent bias in randomized clinical trials.
  • Proper data analysis ensures the integrity and reliability of findings from therapeutic evaluations.